|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.76 AUD | +2.45% |
|
+5.24% | +6.98% |
| 07:13pm | Ramsay Health Care Sees Fiscal 2027 Earnings Uplift Helped by Recent Hospital Acquisition, Says Jefferies | MT |
| Dec. 29 | ASX Most Active Stocks | MT |
| Capitalization | 8.25B 5.51B 4.73B 4.41B 4.1B 7.65B 497B 50.73B 19.93B 238B 20.65B 20.23B 877B | P/E ratio 2026 * |
26.4x | P/E ratio 2027 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 15.4B 10.28B 8.83B 8.24B 7.65B 14.28B 928B 94.68B 37.2B 444B 38.54B 37.75B 1,636B | EV / Sales 2026 * |
0.81x | EV / Sales 2027 * | 0.77x |
| Free-Float |
78.44% | Yield 2026 * |
2.42% | Yield 2027 * | 2.88% |
Last Transcript: Ramsay Health Care Limited
| 1 day | +2.45% | ||
| 1 week | +5.24% | ||
| Current month | +6.98% | ||
| 1 month | +3.99% | ||
| 3 months | +15.78% | ||
| 6 months | -3.72% | ||
| Current year | +6.98% |
| 1 week | 34.75 | 36.76 | |
| 1 month | 33.78 | 36.76 | |
| Current year | 34.38 | 36.76 | |
| 1 year | 30.39 | 39.84 | |
| 3 years | 30.39 | 69.66 | |
| 5 years | 30.39 | 84.58 | |
| 10 years | 30.39 | 84.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Natalie Davis
CEO | Chief Executive Officer | - | - |
Anthony Neilson
DFI | Director of Finance/CFO | 55 | 2025-11-23 |
John Doulis
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Siddle
CHM | Chairman | - | 2014-05-26 |
David Thodey
CHM | Chairman | 72 | 2023-11-27 |
Catriona Deans
BRD | Director/Board Member | 58 | 2018-11-14 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.45% | +5.24% | +6.98% | -45.23% | 5.51B | ||
| -1.05% | -1.52% | +19.35% | +41.54% | 18.6B | ||
| +1.81% | +3.86% | -3.74% | -54.37% | 15.78B | ||
| -0.53% | -2.35% | +8.43% | +69.34% | 11.64B | ||
| -2.39% | -6.93% | +8.36% | +64.37% | 10.09B | ||
| +0.65% | -0.99% | +34.40% | +80.52% | 10.23B | ||
| -2.76% | -8.81% | -26.36% | -41.82% | 8.88B | ||
| -1.98% | -5.34% | -30.14% | - | 7.65B | ||
| +0.21% | -3.28% | +37.13% | +221.94% | 7.59B | ||
| +3.09% | +1.33% | +50.62% | +167.47% | 4.25B | ||
| Average | -0.05% | -1.88% | +10.50% | +55.97% | 10.02B | |
| Weighted average by Cap. | -0.26% | -1.46% | +9.04% | +42.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.04B 12.71B 10.92B 10.19B 9.47B 17.66B 1,148B 117B 46.01B 549B 47.67B 46.7B 2,023B | 19.84B 13.24B 11.38B 10.61B 9.86B 18.4B 1,196B 122B 47.94B 572B 49.67B 48.65B 2,108B |
| Net income | 317M 212M 182M 170M 158M 294M 19.11B 1.95B 766M 9.13B 794M 777M 33.69B | 378M 252M 217M 202M 188M 350M 22.77B 2.32B 913M 10.88B 945M 926M 40.13B |
| Net Debt | 7.15B 4.77B 4.1B 3.82B 3.55B 6.63B 431B 43.94B 17.27B 206B 17.89B 17.52B 759B | 7.07B 4.72B 4.05B 3.78B 3.51B 6.55B 426B 43.45B 17.07B 204B 17.69B 17.32B 751B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-14 | 36.76 $ | +2.45% | 531,313 |
| 26-01-13 | 35.88 $ | -0.19% | 396,960 |
| 26-01-12 | 35.95 $ | +1.70% | 280,470 |
| 26-01-09 | 35.35 $ | -0.92% | 385,048 |
| 26-01-08 | 35.68 $ | +2.15% | 392,670 |
Delayed Quote Australian S.E., January 14, 2026 at 12:10 am EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RHC Stock
Select your edition
All financial news and data tailored to specific country editions
















